MEDIFAST INC (MED) Social Stream
MEDIFAST INC (MED) Price Targets From Analysts
Use the tables below to see what analysts covering MEDIFAST INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued November 7, 2022
The Trend in the Analyst Price Target
MED's average price target has moved up $17.33 over the prior 30 months.
Over the past 43 weeks, MED's average upside potential has been 68.5%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MED Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 17 months, MED's average broker recommendation rating worsened by 1.2.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how MEDIFAST INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 14.64% of that group.
- In the context of stocks in the mid market cap category, MEDIFAST INC's average analyst price target is greater than 584.18% of them.
- MED has a lower variance in analysts' estimates than 3.3% of Food Products stocks.
- MEDIFAST INC's upside potential (average analyst target price relative to current price) is higher than 420.09% of Food Products stocks.
Make investment decisions regarding MED using the data that counts. Try POWR Ratings for free.